Crosstalk between Estrogen Receptor and Growth Factor Receptor Pathways as a Cause for Endocrine Therapy Resistance in Breast Cancer von Osborne, C Kent, Shou, Jiang, Massarweh, Suleiman, Schiff, Rachel

Volltext

Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2–Positive Breast Cancer von Shou, Jiang, Massarweh, Suleiman, Osborne, C. Kent, Wakeling, Alan E., Ali, Simale, Weiss, Heidi, Schiff, Rachel

Volltext

Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy von XIAOJIANG CUI, SCHIFF, Rachel, ARPINO, Grazia, OSBORNE, C. Kent, LEE, Adrian V

Volltext

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action von Osborne, C K, Wakeling, A, Nicholson, R I

Volltext

Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance von Arpino, Grazia, Weiss, Heidi, Lee, Adrian V., Schiff, Rachel, De Placido, Sabino, Osborne, C. Kent, Elledge, Richard M.

Volltext

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases von BARDOU, Valerie-Jeanne, ARPINO, Grazia, ELLEDGE, Richard M, OSBORNE, C. Kent, CLARK, Gary M

Volltext

Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response von Schiff, Rachel, Massarweh, Suleiman, Shou, Jiang, Osborne, C Kent

Volltext

Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase von GUTIERREZ, M. Carolina, DETRE, Simone, JOHNSTON, Stephen, MOHSIN, Syed K, JIANG SHOU, ALLRED, D. Craig, SCHIFF, Rachel, OSBORNE, C. Kent, DOWSETT, Mitch

Volltext

Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance von SCHIFF, Rachel, MASSARWEH, Suleiman A, JIANG SHOU, BHARWANI, Lavina, MOHSIN, Syed K, KENT OSBORNE, C

Volltext

Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer von Osborne, C. Kent, Bardou, Valerie, Hopp, Torsten A., Chamness, Gary C., Hilsenbeck, Susan G., Fuqua, Suzanne A. W., Wong, Jiemin, Allred, D. Craig, Clark, Gary M., Schiff, Rachel

Volltext

Acquired Tamoxifen Resistance: Correlation With Reduced Breast Tumor Levels of Tamoxifen and Isomerization of Trans-4-Hydroxytamoxifen von Osborne, C. Kent, Coronado, Ester, Allred, D. Craig, Wiebe, Valerie, DeGregorio, Michael

Volltext

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study von Hertz, D. L., Kidwell, K. M., Hilsenbeck, S. G., Oesterreich, S., Osborne, C. K., Philips, S., Chenault, C., Hartmaier, R. J., Skaar, T. C., Sikora, M. J., Rae, J. M.

Volltext

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer von HARVEY, J. M, CLARK, G. M, OSBORNE, C. K, ALLRED, D. C

Volltext

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer von Chang, Jenny C, Wooten, Eric C, Tsimelzon, Anna, Hilsenbeck, Susan G, Gutierrez, M Carolina, Elledge, Richard, Mohsin, Syed, Osborne, C Kent, Chamness, Gary C, Allred, D Craig, O'Connell, Peter

Volltext

Comparison of Fulvestrant Versus Tamoxifen for the Treatment of Advanced Breast Cancer in Postmenopausal Women Previously Untreated With Endocrine Therapy: A Multinational, Double-... von HOWELL, Anthony, ROBERTSON, John F. R, OSBORNE, C. Kent, ABRAM, Paul, LICHINITSER, Mikhail R, ELLEDGE, Richard, BAJETTA, Emilio, WATANABE, Toru, MORRIS, Charles, WEBSTER, Alan, DIMERY, Isaiah

Volltext

Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior En... von OSBORNE, C. K, PIPPEN, J, WEBSTER, A, MORRIS, C, ELLEDGE, R, BUZDAR, A, JONES, S. E, PARKER, L. M, ELLIS, M, COME, S, GERTLER, S. Z, MAY, J. T, BURTON, G, DIMERY, I

Volltext

Systemic mirnas as potential biomarkers for malignancy von Healy, N.A., Heneghan, H.M., Miller, N., Osborne, C.K., Schiff, R., Kerin, M.J.

Volltext

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: A Southwest Oncology Group Study von ARPINO, Grazia, GREEN, Stephanie J, ALLRED, D. Craig, LEW, Dannika, MARTINO, Silvana, OSBORNE, C. Kent, ELLEDGE, Richard M

Volltext

Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188) von DAVIDSON, Nancy E, O'NEILL, Anne M, VUKOV, Allen M, OSBORNE, C. Kent, MARTINO, Silvana, WHITE, Douglas R, ABELOFF, Martin D

Volltext

Steroid hormone receptors in breast cancer management von Osborne, C K

Volltext